95 related articles for article (PubMed ID: 31678350)
1. Focal and dose-dependent neuroprotection in ALS mice following AAV2-neurturin delivery.
Gross SK; Shim BS; Bartus RT; Deaver D; McEachin Z; Bétourné A; Boulis NM; Maragakis NJ
Exp Neurol; 2020 Jan; 323():113091. PubMed ID: 31678350
[TBL] [Abstract][Full Text] [Related]
2. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
[TBL] [Abstract][Full Text] [Related]
3. Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: support for nigral targeting in Parkinson's disease.
Bartus RT; Brown L; Wilson A; Kruegel B; Siffert J; Johnson EM; Kordower JH; Herzog CD
Neurobiol Dis; 2011 Oct; 44(1):38-52. PubMed ID: 21704161
[TBL] [Abstract][Full Text] [Related]
4. Enhanced neurotrophic distribution, cell signaling and neuroprotection following substantia nigral versus striatal delivery of AAV2-NRTN (CERE-120).
Herzog CD; Brown L; Kruegel BR; Wilson A; Tansey MG; Gage FH; Johnson EM; Bartus RT
Neurobiol Dis; 2013 Oct; 58():38-48. PubMed ID: 23631873
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Safety of Patients with Parkinson's Disease Receiving rAAV2-Neurturin (CERE-120) Gene Transfer.
Marks WJ; Baumann TL; Bartus RT
Hum Gene Ther; 2016 Jul; 27(7):522-7. PubMed ID: 26711317
[TBL] [Abstract][Full Text] [Related]
6. AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS.
Leyton-Jaimes MF; Kahn J; Israelson A
Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14755-14760. PubMed ID: 31262807
[TBL] [Abstract][Full Text] [Related]
7. Bioactivity of AAV2-neurturin gene therapy (CERE-120): differences between Parkinson's disease and nonhuman primate brains.
Bartus RT; Herzog CD; Chu Y; Wilson A; Brown L; Siffert J; Johnson EM; Olanow CW; Mufson EJ; Kordower JH
Mov Disord; 2011 Jan; 26(1):27-36. PubMed ID: 21322017
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.
Wang LJ; Lu YY; Muramatsu S; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Matsushita T; Hanazono Y; Kume A; Nagatsu T; Ozawa K; Nakano I
J Neurosci; 2002 Aug; 22(16):6920-8. PubMed ID: 12177190
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
[TBL] [Abstract][Full Text] [Related]
10. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue.
Vallarola A; Sironi F; Tortarolo M; Gatto N; De Gioia R; Pasetto L; De Paola M; Mariani A; Ghosh S; Watson R; Kalmes A; Bonetto V; Bendotti C
J Neuroinflammation; 2018 Mar; 15(1):65. PubMed ID: 29495962
[TBL] [Abstract][Full Text] [Related]
11. Gene transfer for neuroprotection in animal models of Parkinson's disease and amyotrophic lateral sclerosis.
Bohn MC; Connor B; Kozlowski DA; Mohajeri MH
Novartis Found Symp; 2000; 231():70-89; discussion 89-93. PubMed ID: 11131547
[TBL] [Abstract][Full Text] [Related]
12. An anthocyanin-enriched extract from strawberries delays disease onset and extends survival in the hSOD1
Winter AN; Ross EK; Wilkins HM; Stankiewicz TR; Wallace T; Miller K; Linseman DA
Nutr Neurosci; 2018 Jul; 21(6):414-426. PubMed ID: 28276271
[TBL] [Abstract][Full Text] [Related]
13. MicroNeurotrophins Improve Survival in Motor Neuron-Astrocyte Co-Cultures but Do Not Improve Disease Phenotypes in a Mutant SOD1 Mouse Model of Amyotrophic Lateral Sclerosis.
Glajch KE; Ferraiuolo L; Mueller KA; Stopford MJ; Prabhkar V; Gravanis A; Shaw PJ; Sadri-Vakili G
PLoS One; 2016; 11(10):e0164103. PubMed ID: 27716798
[TBL] [Abstract][Full Text] [Related]
14. AAV2-mediated delivery of human neurturin to the rat nigrostriatal system: long-term efficacy and tolerability of CERE-120 for Parkinson's disease.
Gasmi M; Brandon EP; Herzog CD; Wilson A; Bishop KM; Hofer EK; Cunningham JJ; Printz MA; Kordower JH; Bartus RT
Neurobiol Dis; 2007 Jul; 27(1):67-76. PubMed ID: 17532642
[TBL] [Abstract][Full Text] [Related]
15. Expression, bioactivity, and safety 1 year after adeno-associated viral vector type 2-mediated delivery of neurturin to the monkey nigrostriatal system support cere-120 for Parkinson's disease.
Herzog CD; Brown L; Gammon D; Kruegel B; Lin R; Wilson A; Bolton A; Printz M; Gasmi M; Bishop KM; Kordower JH; Bartus RT
Neurosurgery; 2009 Apr; 64(4):602-12; discussion 612-3. PubMed ID: 19349823
[TBL] [Abstract][Full Text] [Related]
16. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
[TBL] [Abstract][Full Text] [Related]
17. Neuregulin 1 confers neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons.
Lasiene J; Komine O; Fujimori-Tonou N; Powers B; Endo F; Watanabe S; Shijie J; Ravits J; Horner P; Misawa H; Yamanaka K
Acta Neuropathol Commun; 2016 Feb; 4():15. PubMed ID: 26891847
[TBL] [Abstract][Full Text] [Related]
18. Tempol improves neuroinflammation and delays motor dysfunction in a mouse model (SOD1
Chiarotto GB; Cartarozzi LP; Perez M; Biscola NP; Spejo AB; Gubert F; França Junior M; Mendez-Otero R; de Oliveira ALR
J Neuroinflammation; 2019 Nov; 16(1):218. PubMed ID: 31727149
[TBL] [Abstract][Full Text] [Related]
19. MRI of the cervical spinal cord predicts respiratory dysfunction in ALS.
Grolez G; Kyheng M; Lopes R; Moreau C; Timmerman K; Auger F; Kuchcinski G; Duhamel A; Jissendi-Tchofo P; Besson P; Laloux C; Petrault M; Devedjian JC; Pérez T; Pradat PF; Defebvre L; Bordet R; Danel-Brunaud V; Devos D
Sci Rep; 2018 Jan; 8(1):1828. PubMed ID: 29379040
[TBL] [Abstract][Full Text] [Related]
20. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis.
Kim J; Kim TY; Cho KS; Kim HN; Koh JY
Neurobiol Dis; 2013 Nov; 59():80-5. PubMed ID: 23891729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
